The Australian Shepherd is an intelligent, high-drive herding breed beloved for its versatility, trainability, and striking appearance. With a typical lifespan of 12–15 years, Aussies can be healthy, active companions for many years — but only if their owners are educated about breed-specific health risks. The four most critical health concerns for this breed are the MDR1 gene mutation and its life-threatening drug interactions, Collie Eye Anomaly (CEA), idiopathic epilepsy, and hip dysplasia.

MDR1 / ABCB1 Gene Mutation: A Potentially Lethal Drug Sensitivity

The multidrug resistance gene (MDR1, also called ABCB1) encodes P-glycoprotein, a protein that acts as a molecular pump in the blood-brain barrier, actively removing certain drugs before they accumulate to toxic levels in the brain. Australian Shepherds, Collies, Shetland Sheepdogs, and several other herding breeds commonly carry a deletion mutation in this gene that cripples P-glycoprotein function. Dogs with two copies of the mutant allele (homozygous affected) have severely impaired drug efflux; dogs with one copy (heterozygous carriers) have intermediate risk.

Which Drugs Are Dangerous?

The list of drugs that can cause toxicity in MDR1-affected dogs is extensive and includes medications that veterinarians and owners may encounter routinely:

• Ivermectin — used in many heartworm preventatives and broad-spectrum dewormers. Even doses considered safe for other dogs can cause fatal neurological toxicity in affected Aussies. Note: the low doses in standard monthly heartworm prevention products like Heartgard are generally safe even in affected dogs — but higher-dose ivermectin formulations are extremely dangerous.
• Loperamide (Imodium) — an over-the-counter anti-diarrhoeal available in every pharmacy. Seemingly harmless but potentially lethal in affected dogs.
• Selamectin, milbemycin, moxidectin — other antiparasitic drugs; risk varies by drug and dose.
• Vincristine, doxorubicin — chemotherapy drugs that accumulate in the CNS of affected dogs.
• Acepromazine — a sedative commonly used in veterinary anaesthesia; causes profound, prolonged sedation in affected dogs.
• Butorphanol — an opioid pain reliever with heightened CNS effects in affected dogs.

Signs of MDR1 toxicity include: dilated pupils, disorientation, excessive salivation, vomiting, muscle tremors, apparent blindness, seizures, coma, and respiratory depression. Treatment is supportive only — there is no antidote. Recovery depends entirely on how much drug was administered and how quickly supportive care is initiated.

What To Do

DNA testing for the MDR1/ABCB1 mutation is widely available, inexpensive, and definitive. A simple cheek swab sent to an accredited laboratory (Washington State University Veterinary Clinical Pharmacology Lab offers the validated test) provides a result of Normal/Normal, Mutant/Normal (carrier), or Mutant/Mutant (affected). Test your dog before any veterinary procedure or new medication. Once you have the result, document it prominently in your dog’s records and inform every vet who treats your dog.

Collie Eye Anomaly (CEA)

CEA is an inherited developmental defect affecting the choroid (the blood vessel layer beneath the retina). It ranges in severity from mild choroidal hypoplasia — which may not significantly affect vision — to retinal detachment and blindness. The condition is present at birth and caused by a recessive mutation that can be identified by DNA testing. Lesions are most easily detected in puppies aged 5–8 weeks before normal pigmentation makes them harder to see; an experienced veterinary ophthalmologist should examine puppies at this age. Responsible breeders test all breeding stock. While mild CEA is common in the breed, severe forms leading to blindness are less frequent.

Epilepsy & Idiopathic Seizures

Idiopathic epilepsy — recurrent seizures with no identifiable underlying cause — occurs with meaningful frequency in Australian Shepherds. The condition is presumed to be genetic, though the specific genes involved are not fully characterised. Seizures typically first appear between ages 1 and 5. They can range from brief focal episodes (twitching, staring, fly-biting behaviour) to generalised tonic-clonic convulsions lasting 1–3 minutes.

A single isolated seizure does not always require immediate medication, but dogs with multiple seizures per month, cluster seizures (more than two seizures within 24 hours), or prolonged seizures (status epilepticus) are typically placed on antiepileptic medication. Phenobarbital and potassium bromide are the most commonly used first-line treatments. Dogs on phenobarbital require regular liver function monitoring. Status epilepticus is a medical emergency requiring immediate veterinary treatment with IV anticonvulsants.

Hip Dysplasia

Australian Shepherds are at moderate risk for hip dysplasia, a malformation of the hip joint that leads to progressive osteoarthritis. Signs include reluctance to exercise, difficulty rising, a bunny-hopping gait, and muscle wasting over the hindquarters. OFA or PennHIP evaluation of breeding stock is standard practice in responsible breeding programmes. For affected dogs, management includes weight optimisation, controlled exercise, omega-3 supplementation, physical therapy, and anti-inflammatory medication. Total hip replacement surgery offers the best long-term outcome in severely affected dogs.

References

1. Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001;11(8):727–733. PMID: 11692082
2. Donner J, Freyer J, Davison S, et al. Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics. 2023;19(2):e1010651. PMID: 36780558